Location History:
- Jerusalem, IL (2005 - 2009)
- Har-Adar, IL (2009 - 2018)
Company Filing History:
Years Active: 2005-2018
Title: Gideon Halperin: Innovating in High-Purity Phospholipids
Introduction
Gideon Halperin, based in Har-Adar, Israel, is a prolific inventor with a significant contribution to the field of biochemistry, particularly in the development of high-purity phospholipids. With a remarkable portfolio of 20 patents, Halperin has focused on novel synthetic routes that are key to industrial applications in therapeutics.
Latest Patents
His latest patents introduce groundbreaking methods for the industrial preparation of therapeutically beneficial oxidized phospholipids. These patents detail innovative methods for efficiently creating compounds with a glycerolic backbone that incorporate one or more oxidized moieties without the need for column chromatography. Additionally, these patents disclose new methods for introducing phosphorus-containing moieties, such as phosphate, to glycerolic backbone compounds. Notably, one of the significant inventions includes the production of substantially pure 1-hexadecyl-2-(4'-carboxy)butyl-sn-glycero-3-phosphocholine (CI-201), showcasing his commitment to advancing therapeutic research.
Career Highlights
Throughout his career, Gideon Halperin has made substantial contributions while working for Vascular Biogenics Ltd., where he has collaborated with other notable experts in the field. His work has had a significant impact on the development of innovative solutions in biochemistry, especially focusing on phospholipids.
Collaborations
Halperin has collaborated with several professionals, including Eti Kovalevski-Ishai and Dror Harats, which has enhanced the innovation process and overall output of their work in the biochemistry sector.
Conclusion
Gideon Halperin stands out as an influential inventor who has made remarkable strides in the field of high-purity phospholipids. His innovative patents not only contribute to the scientific community but also pave the way for advancements in therapeutic applications, solidifying his reputation as a leader in biochemistry.